Calabrese Angelo MD entered the industry of Internal Medicine Doctors in 1995 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Internal Medicine Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Internal Medicine Doctors. The business provides service to the B2C market.
To acquire more information, please contact Angelo Calabrese by calling (201) 246-1111 during business hours. You can also write to the business’ Single Location at 25 Locust Avenue, North Arlington, New Jersey NJ 07031. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Calabrese Angelo MD |
Representative: | Angelo Calabrese |
Place of Business: | 25 Locust Avenue, North Arlington, NJ 07031 |
Contact Number: | (201) 246-1111 |
Type of Service: | Internal Medicine Doctors |
SIC Number: | 8011 |
NAICS Number: | 6211110 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 1995 |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Calabrese Angelo MD is a company operating from Bergen, New Jersey providing professional Internal Medicine Doctors and relevant B2C variables. It was founded in 1995 and registered with the SIC code 8011 as Internal Medicine Doctors, and with the NAICS code 6211110 as Internal Medicine Doctors.
With a current employee count of 1 to 4, Calabrese Angelo MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Angelo Calabrese at (201) 246-1111 for related queries, or to locate its Single Location using the coordinates 40.795655,-74.136973.
The Single Location can also be found at the street address 25 Locust Avenue in North Arlington, New Jersey 07031 and can be engaged online through the company website at , the company Twitter , and Facebook page .